Paxman AB (PXMBF)
3.50
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Paxman Gross Profit Margin (Quarterly) : 3.65% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.65% |
| March 31, 2026 | 0.19% |
| December 31, 2025 | -3.57% |
| September 30, 2025 | 1.09% |
| June 30, 2025 | 0.77% |
| March 31, 2025 | 9.24% |
| December 31, 2024 | 10.59% |
| September 30, 2024 | 13.11% |
| June 30, 2024 | 16.72% |
| March 31, 2024 | 12.63% |
| December 31, 2023 | 8.21% |
| September 30, 2023 | 13.28% |
| June 30, 2023 | 3.11% |
| March 31, 2023 | -3.92% |
| December 31, 2022 | 20.47% |
| September 30, 2022 | 1.92% |
| June 30, 2022 | -10.83% |
| March 31, 2022 | -24.67% |
| December 31, 2021 | 1.28% |
| Date | Value |
|---|---|
| September 30, 2021 | -20.61% |
| June 30, 2021 | -16.78% |
| March 31, 2021 | -11.27% |
| December 31, 2020 | -35.94% |
| September 30, 2020 | -12.60% |
| June 30, 2020 | -9.57% |
| March 31, 2020 | 12.59% |
| December 31, 2019 | -12.95% |
| September 30, 2019 | 5.60% |
| June 30, 2019 | 2.79% |
| March 31, 2019 | -1.29% |
| December 31, 2018 | -11.75% |
| September 30, 2018 | -1.34% |
| June 30, 2018 | -6.16% |
| March 31, 2018 | -14.81% |
| December 31, 2017 | -69.56% |
| September 30, 2017 | -20.52% |
| June 30, 2017 | -3.41% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Getinge AB | 49.35% |
| Xvivo Perfusion AB | 63.23% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.22% |
| Return on Assets | -1.05% |
| Return on Invested Capital | -1.19% |
| Profit Margin (Quarterly) | 2.44% |
| Operating Margin (Quarterly) | 3.65% |
| Return on Net Operating Assets | -1.77% |